Clinical Trial Update: Study to Evaluate Potential Decrease in Hospitalization Events, Time Between Events, and Increasing Longevity in Patients With Symptomatic Heart Failure (0954-948) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update from Organon evaluating a heart failure therapy for reducing hospitalizations, increasing time between events, and improving longe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Organon trial medication

Snippet

Sponsor: Organon and Co | Conditions: Heart Failure | Phase 3 | Status: COMPLETED | Results posted: 2010-08-02